Published online before print February 5, 2004, doi: 10.1161/01.RES.0000120861.27064.09
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
Molecular Medicine |
Homeobox A9 Transcriptionally Regulates the EphB4 Receptor to Modulate Endothelial Cell Migration and Tube Formation
From Molecular Cardiology, Department of Internal Medicine IV (T.B., C.U., A.M.Z., S.D.), University of Frankfurt, Frankfurt, Germany; the Department of Thoracic and Cardiovascular Surgery (D.A.), University Hospital Homburg/Saar; and Max Planck Institute of Neurobiology (A.A.-P.), Martinsried, Germany.
Correspondence to Stefanie Dimmeler, PhD, Molecular Cardiology, Dept of Internal Medicine IV, University of Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. E-mail Dimmeler{at}em.uni-frankfurt.de
Homeobox genes (Hox) encode for transcription factors, which regulate cell proliferation and migration and play an important role in the development of the cardiovascular system during embryogenesis. In this study, we investigated the role of HoxA9 for endothelial cell migration and angiogenesis in vitro and identified a novel target gene, the EphB4 receptor. Inhibition of HoxA9 expression decreased endothelial cell tube formation and inhibited endothelial cell migration, suggesting that HoxA9 regulates angiogenesis. Because Eph receptor tyrosine kinases importantly contribute to angiogenesis, we examined whether HoxA9 may transcriptionally regulate the expression of EphB4. Downregulation of HoxA9 reduced the expression of EphB4. Chromatin-immunoprecipitation revealed that HoxA9 interacted with the EphB4 promoter, whereas a deletion construct of HoxA9 without DNA-binding motif (
aa 206-272) did not bind. Consistently, HoxA9 wild-type overexpression activated the EphB4 promoter as determined by reporter gene expression. HoxA9 binds to the EphB4 promoter and stimulates its expression resulting in an increase of endothelial cell migration and tube forming activity. Thus, modulation of EphB4 expression may contribute to the proangiogenic effect of HoxA9 in endothelial cells.
Key Words: homeobox • migration • angiogenesis • Eph receptor • endothelial cells
This article has been cited by other articles:
 |
|
 |
|
  K. Harada, T. Yamazaki, C. Iwata, Y. Yoshimatsu, H. Sase, K. Mishima, Y. Morishita, M. Hirashima, Y. Oike, T. Suda, et al. Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis J. Cell Sci., November 1, 2009; 122(21): 3923 - 3930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Urbich, L. Rossig, D. Kaluza, M. Potente, J.-N. Boeckel, A. Knau, F. Diehl, J.-G. Geng, W.-K. Hofmann, A. M. Zeiher, et al. HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells Blood, May 28, 2009; 113(22): 5669 - 5679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kawakami, Y. Uchiyama, C. Rodriguez Esteban, T. Inenaga, N. Koyano-Nakagawa, H. Kawakami, M. Marti, M. Kmita, P. Monaghan-Nichols, R. Nishinakamura, et al. Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities Development, February 15, 2009; 136(4): 585 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pirro, F. Bagaglia, L. Paoletti, R. Razzi, and M. R. Mannarino Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 329 - 339. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Mannarino and M. Pirro Endothelial Injury and Repair: A Novel Theory for Atherosclerosis Angiology, August 1, 2008; 59(2_suppl): 69S - 72S. [Abstract] [PDF]
|
|
|
|
 |
|
 A. C. Webler, R. Popp, T. Korff, U. R. Michaelis, C. Urbich, R. Busse, and I. Fleming Cytochrome P450 2C9-Induced Angiogenesis Is Dependent on EphB4 Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1123 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen and D. H. Gorski Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5 Blood, February 1, 2008; 111(3): 1217 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bandyopadhyay, M. Z. Ashraf, P. Daher, P. H. Howe, and P. E. DiCorleto HOXA9 Participates in the Transcriptional Activation of E-Selectin in Endothelial Cells Mol. Cell. Biol., June 15, 2007; 27(12): 4207 - 4216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-L. Hu, E. Passegue, S. Fong, C. Largman, and H. J. Lawrence Evidence that the Pim1 kinase gene is a direct target of HOXA9 Blood, June 1, 2007; 109(11): 4732 - 4738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Suzuki, H. Urushitani, T. Sato, T. Kobayashi, H. Watanabe, Y. Ohta, and T. Iguchi Gene Expression Change in the Mullerian Duct of the Mouse Fetus Exposed to Diethylstilbestrol In Utero Experimental Biology and Medicine, April 1, 2007; 232(4): 503 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Diehl, L. Rossig, A. M. Zeiher, S. Dimmeler, and C. Urbich The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation Blood, February 15, 2007; 109(4): 1472 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, A. D. Leal, S. Patel, and D. H. Gorski The Homeobox Gene GAX Activates p21WAF1/CIP1 Expression in Vascular Endothelial Cells through Direct Interaction with Upstream AT-rich Sequences J. Biol. Chem., January 5, 2007; 282(1): 507 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hamik, B. Wang, and M. K. Jain Transcriptional Regulators of Angiogenesis Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 1936 - 1947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Reynolds, M. Sigaroudinia, G. Zardo, M. B. Wilson, G. M. Benton, C. J. Miller, C. Hong, J. Fridlyand, J. F. Costello, and T. D. Tlsty Tumor Suppressor p16INK4A Regulates Polycomb-mediated DNA Hypermethylation in Human Mammary Epithelial Cells J. Biol. Chem., August 25, 2006; 281(34): 24790 - 24802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Daftary and H. S. Taylor Endocrine Regulation of HOX Genes Endocr. Rev., June 1, 2006; 27(4): 331 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Salsi and V. Zappavigna Hoxd13 and Hoxa13 Directly Control the Expression of the EphA7 Ephrin Tyrosine Kinase Receptor in Developing Limbs J. Biol. Chem., January 27, 2006; 281(4): 1992 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cobb and D. Duboule Comparative analysis of genes downstream of the Hoxd cluster in developing digits and external genitalia Development, July 1, 2005; 132(13): 3055 - 3067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Mace, S. L. Hansen, C. Myers, D. M. Young, and N. Boudreau HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair J. Cell Sci., June 15, 2005; 118(12): 2567 - 2577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rossig, C. Urbich, T. Bruhl, E. Dernbach, C. Heeschen, E. Chavakis, K.-i. Sasaki, D. Aicher, F. Diehl, F. Seeger, et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells J. Exp. Med., June 6, 2005; 201(11): 1825 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Xia, S. R. Kumar, R. Masood, S. Zhu, R. Reddy, V. Krasnoperov, D. I. Quinn, S. M. Henshall, R. L. Sutherland, J. K. Pinski, et al. EphB4 Expression and Biological Significance in Prostate Cancer Cancer Res., June 1, 2005; 65(11): 4623 - 4632. [Abstract] [Full Text] [PDF]
|
|